Current Yachts announced its official launch with a mission to transform the yacht brokerage industry by eliminating excessive commissions and putting consumers first. The company's innovative model is a service-based, patent-pending approach, where traditional 8-10% commission structures are replaced with transparent, flat-rate pricing while maintaining the highest professional standards.
Read MoreConsero Global Fortifies Executive Leadership with Key Technology and Corporate Development Appointments to Accelerate Growth and Innovation
Read MoreNew Capabilities Place Peer-reviewed Literature Review Evidence at the Fingertips of Research and Commercial Teams to Align Decision-making and Improve Productivity
Read More
Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout [1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics ("Isto") from Thompson Street Capital Partners ("TSCP"). TSCP will retain a minority stake, alongside Isto Biologics' management team.